A detailed history of Caption Management, LLC transactions in Standard Biotools Inc. stock. As of the latest transaction made, Caption Management, LLC holds 20,000 shares of LAB stock, worth $36,600. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,000
Previous 20,000 -0.0%
Holding current value
$36,600
Previous $35,000 8.57%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$1.65 - $2.92 $13,200 - $23,360
8,000 New
8,000 $14,000
Q4 2021

Feb 11, 2022

SELL
$3.63 - $6.13 $266,895 - $450,708
-73,525 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$5.5 - $7.41 $404,387 - $544,820
73,525 New
73,525 $485,000
Q2 2021

Aug 16, 2021

SELL
$4.35 - $6.35 $542,153 - $791,419
-124,633 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$3.94 - $7.09 $321,634 - $578,777
81,633 Added 189.84%
124,633 $562,000
Q4 2020

Feb 16, 2021

BUY
$5.45 - $8.65 $234,350 - $371,950
43,000 New
43,000 $258,000

Others Institutions Holding LAB

About STANDARD BIOTOOLS INC.


  • Ticker LAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 78,654,800
  • Market Cap $144M
  • Description
  • Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...
More about LAB
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.